Biotoxtech Co., Ltd. (KOSDAQ:086040)
South Korea
· Delayed Price · Currency is KRW 2,620.00
0.00 (0.00%)
At close: Dec 5, 2025
Biotoxtech Revenue
Biotoxtech had revenue of 11.90B KRW in the quarter ending September 30, 2025, with 7.01% growth. This brings the company's revenue in the last twelve months to 44.19B, up 14.95% year-over-year. In the year 2024, Biotoxtech had annual revenue of 41.34B with 26.69% growth.
Revenue (ttm)
44.19B
Revenue Growth
+14.95%
P/S Ratio
0.93
Revenue / Employee
235.06M
Employees
188
Market Cap
41.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.34B | 8.71B | 26.69% |
| Dec 31, 2023 | 32.63B | -4.66B | -12.50% |
| Dec 31, 2022 | 37.29B | 4.57B | 13.98% |
| Dec 31, 2021 | 32.72B | 6.29B | 23.80% |
| Dec 31, 2020 | 26.43B | 574.78M | 2.22% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| KB Financial Group | 14.89T |
| HD Hyundai Heavy Industries | 16.39T |